Genevieve Claire Combes - 09 Dec 2025 Form 4 Insider Report for HARTE HANKS INC (HHS)

Role
Director
Signature
/s/ Robert Wyman, Attorney-in-fact for Genevieve Combes
Issuer symbol
HHS
Transactions as of
09 Dec 2025
Net transactions value
+$89,991
Form type
4
Filing time
15 Dec 2025, 16:03:12 UTC
Previous filing
31 May 2024
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Combes Genevieve Claire Director 1 EXECUTIVE DRIVE, SUITE 303, CHELMSFORD /s/ Robert Wyman, Attorney-in-fact for Genevieve Combes 15 Dec 2025 0001383909

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HHS Common Stock Award $89,991 +27,861 $3.23 27,861 09 Dec 2025 RSU shares held by Harte Hanks, granted to the participant but not yet vested F1
holding HHS Common Stock 12,048 09 Dec 2025 RSU shares held by Harte Hanks, granted to the participant but not yet vested F2
holding HHS Common Stock 26,283 09 Dec 2025 Direct
holding HHS Common Stock 16,216 09 Dec 2025 RSU shares held by Harte Hanks, granted to the participant but not yet vested F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Participant was granted 27,861 RSU shares on 12/09/2025 that will vest 100% on the first anniversary of the grant date.
F2 Participant was granted 12,048 RSU shares on 5/23/2024 that vested 100% on 5/23/.2025, but the participant chose to defer receipt of the vested shares until a later date.
F3 Participant was granted 16,216 RSU shares on 8/17/2023 that vested 100% on 8/17/2024, but the participant chose to defer receipt of the vested shares until a later date.